Integrity Alliance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Integrity Alliance's BMY Position: Q2 2026 in Review
Integrity Alliance reduced its Bristol-Myers Squibb (BMY) stake by 40% in Q2 2026, selling an estimated $812K and leaving 21,389 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #308.
Integrity Alliance first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.15M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Integrity Alliance held 21,389 shares of Bristol-Myers Squibb worth $1.23M as of Q2 2026.
- Integrity Alliance sold 14,138 Bristol-Myers Squibb shares in Q2 2026, an estimated $812K.
- Bristol-Myers Squibb made up 0.04% of Integrity Alliance's portfolio in Q2 2026, its #308 holding.
- Integrity Alliance first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- Integrity Alliance's Bristol-Myers Squibb position peaked at $2.15M in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.